绿竹生物-B(02480)公布中期业绩 净亏损6162.2万元 同比减少20.6%

智通财经
Aug 26

智通财经APP讯,绿竹生物-B(02480)公布2026年中期业绩,其他收入676.2万元,同比增长39.4%;研发开支3033.1万元,同比减少39.7%;净亏损6162.2万元,同比减少20.6%;每股亏损0.31元。

公告称,其他收入增长乃主要由于政府补助及租赁收入增加,部分被利息收入及免疫检测试剂盒销售收入的降低所抵销。

研发开支减少主要由于研发开支与研发管线进展相关,因多数管线品种处于临床前阶段,列支研发费用较低。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10